Assessment of Indocyanine Green excretion using pinpoint endoscopic fluorescence imaging system for diagnosis of biliary atresia; prospective study.

Assessment of Indocyanine Green excretion using pinpoint endoscopic fluorescence imaging system for diagnosis of biliary atresia; prospective study. - Diagnosis of biliary atresia: assessment of Indocyanine Green excretion.

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000027972

Enrollment

Registered

2017-07-01

Start date

2017-01-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Biliary atresia

Interventions

To inject the &quot

Indocyanine Green&quot

(0.5mg/kg) within 30 seconds.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Children with intractable jaundice, with possible diagnosis of biliary atresia.

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
After injection of "Indocyanine Green", all feces (within 12 hours post-injection) are exposed by Pinpoint endoscopic fluorescence imaging system, to see if "Indocyanine Green" is contained or not.	—

Countries

Japan

Contacts

Public ContactGo Miyano

Juntendo University School of Medicine Pediatric Surgery

go@juntendo.ac.jp03-3813-3111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026